Isabella Ogorek

512 citations
10 papers · 357 indexed · h-index 7
Topics
Alzheimer's disease research and treatments (7 papers)Nuclear Receptors and Signaling (2 papers)Neuroinflammation and Neurodegeneration Mechanisms (2 papers)
Partner nations
GermanyCzechiaBelgium

In The Last Decade

Isabella Ogorek

10 papers receiving 354 citations

Peers

Isabella Ogorek
Comparison fields: 5 of 68
  • Physiology 169
  • Molecular Biology 124
  • Neurology 100
  • Neurology 44
  • Cancer Research 35
Replace Silvia Catricalà with:
Silvia Catricalà Italy
Marie‐Christine Boucau France
Norah K. Algarzae Saudi Arabia
Stefania Ippati Italy
Yutaro Hoshi Japan
Kenji Ikeda Japan
Israel C. Nnah United States
Ya Jie Meng China
Jingru Qian Singapore
Jun‐Chun Tang China
Isabella Ogorek relative to Silvia Catricalà Italy Silvia Catricalà's profile →
Citations per field
00.5×3.3×
Silvia Catricalà · 1×
Citations per year

Countries citing papers authored by Isabella Ogorek

Since Specialization
Citations

This map shows the geographic impact of Isabella Ogorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabella Ogorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabella Ogorek more than expected).

Fields of papers citing papers by Isabella Ogorek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabella Ogorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabella Ogorek. The network helps show where Isabella Ogorek may publish in the future.

Co-authorship network of co-authors of Isabella Ogorek

This figure shows the co-authorship network connecting the top 25 collaborators of Isabella Ogorek. A scholar is included among the top collaborators of Isabella Ogorek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabella Ogorek. Isabella Ogorek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 2
2 12
3 16
4 96
5 45
6 54
7 12
8 5
9 109
10 6

About Isabella Ogorek

Isabella Ogorek is a scholar working on Physiology, Neurology and Clinical Biochemistry, having authored 10 papers that have together received 357 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Nuclear Receptors and Signaling (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Neurology (100 citations), Physiology (169 citations) and Clinical Biochemistry (30 citations). Isabella Ogorek has collaborated with scholars based in Germany, Czechia and Belgium. Frequent co-authors include Sascha Weggen, Oliver Wirths, Jens Wiltfang, Melanie Hüttenrauch, Hans‐Wolfgang Klafki, Markus Otto, Christine Stadelmann, L Donner, Nina Sarah Gowert and Jens W. Fischer. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026